Ashish Jha, the dean of the Brown School of Public Health who served as the White House COVID-19 Response Coordinator. "The data so far suggest that the new COVID vaccines should be really quite effective against even the new emerging variants that we have seen come up in the last weeks," Dr. The vaccine makers and FDA say that the vaccine should still provide good protection against COVID. The vaccines target the omicron subvariant called XBB.1.5, which is no longer the most common strain in circulation. We very much encourage those who are eligible to consider getting vaccinated." "The public can be assured that these updated vaccines have met the agency's rigorous scientific standards for safety, effectiveness, and manufacturing quality. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, in a statement. "Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death," said Dr. The vaccines from Moderna and Pfizer and its partner BioNTech were approved Monday for people 12 and older and under an emergency use authorization for children ages 6 months to 11 years old. The Food and Drug Administration approved a new round of vaccines against COVID-19. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5. Another round of COVID-19 vaccines is on the way.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |